6.31
price down icon0.47%   -0.03
pre-market  Vorhandelsmarkt:  6.26   -0.05   -0.79%
loading
Schlusskurs vom Vortag:
$6.34
Offen:
$6.33
24-Stunden-Volumen:
77,166
Relative Volume:
0.71
Marktkapitalisierung:
$23.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.11M
KGV:
-4.1242
EPS:
-1.53
Netto-Cashflow:
$-28.18M
1W Leistung:
-5.68%
1M Leistung:
-6.93%
6M Leistung:
-45.02%
1J Leistung:
-74.18%
1-Tages-Spanne:
Value
$6.20
$6.39
1-Wochen-Bereich:
Value
$6.20
$6.7999
52-Wochen-Spanne:
Value
$5.3495
$28.34

Tempest Therapeutics Inc Stock (TPST) Company Profile

Name
Firmenname
Tempest Therapeutics Inc
Name
Telefon
415-798-8589
Name
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE
Name
Mitarbeiter
5
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
TPST's Discussions on Twitter

Vergleichen Sie TPST mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TPST
Tempest Therapeutics Inc
6.31 24.64M 0 -31.11M -28.18M -1.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-10 Herabstufung H.C. Wainwright Buy → Neutral
2025-04-10 Herabstufung Scotiabank Sector Outperform → Sector Perform
2024-03-14 Eingeleitet Scotiabank Sector Outperform
2024-02-08 Eingeleitet Jefferies Buy

Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Tempest Therapeutics Inc. stockBreakout stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Tempest Therapeutics Inc. a good long term investmentRapid profit acceleration - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Tempest Therapeutics Inc. Stock Analysis and ForecastExplosive wealth accumulation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives Tempest Therapeutics Inc. stock priceTriple-digit wealth increases - Autocar Professional

Jul 21, 2025
pulisher
Jul 18, 2025

Is Tempest Therapeutics Inc. stock a growth or value playSmart High Yield Swing Trades - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

Why Tempest Therapeutics Inc. stock attracts strong analyst attentionPrecision Entry Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Tempest Therapeutics Inc. stock performs during market volatilityFree Real-Time Trading Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Tempest Therapeutics Inc. stock price move sharplyFree Access to Community - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Head-To-Head Contrast: Tempest Therapeutics (NASDAQ:TPST) vs. Relmada Therapeutics (NASDAQ:RLMD) - Defense World

Jul 09, 2025
pulisher
Jul 05, 2025

Tempest Therapeutics (NASDAQ:TPST) Trading Up 0.2% – Here’s Why - Defense World

Jul 05, 2025
pulisher
Jul 02, 2025

Tempest Therapeutics’ Promising Advances in Liver Cancer Treatment - TipRanks

Jul 02, 2025
pulisher
Jun 30, 2025

Tempest Receives Clearance to Proceed with Pivotal Trial of - GlobeNewswire

Jun 30, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Acquires Shares of 189,506 Tempest Therapeutics, Inc. (NASDAQ:TPST) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Tempest Therapeutics Secures $4.1M in Direct Offering - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

SEC Form 424B5 filed by Tempest Therapeutics Inc. - Quantisnow

Jun 12, 2025
pulisher
Jun 12, 2025

Form 424B5 Tempest Therapeutics, - StreetInsider

Jun 12, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics Announces $4.6 Mln Registered Direct Offering With Institutional Investor - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics (TPST) Announces New Stock Purchase Agreeme - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics ends ATM prospectus with Jefferies By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics, Inc. Announces $4.6 Million Registered Direct Offering of Common Stock - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics announces $4.6 million registered direct offering - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics ends ATM prospectus with Jefferies - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics Terminates ATM Prospectus Supplement Dated February 6, 2025SEC Filing - MarketScreener

Jun 11, 2025
pulisher
Jun 11, 2025

Tempest Therapeutics Raises $4.6M From Single Institutional Investor: Strategic Alternative Process Funded - Stock Titan

Jun 11, 2025
pulisher
Jun 09, 2025

Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 09, 2025
pulisher
Jun 09, 2025

Pre-market Movers: KLTO, TPST, PYPD, MOVE... - RTTNews

Jun 09, 2025
pulisher
Jun 06, 2025

Tempest Therapeutics Shifts Executives to Consulting Roles - TipRanks

Jun 06, 2025
pulisher
Jun 05, 2025

Tempest Therapeutics stock rises on EMA Orphan Drug Designation By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Tempest Therapeutics stock rises on EMA Orphan Drug Designation - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Tempest Therapeutics Says Amezalpat Gets EMA Orphan Drug Designation in Liver Cancer - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

Tempest Therapeutics: European Medicines Agency Grants Orphan Drug Designation To Amezalpat - Nasdaq

Jun 05, 2025

Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):